2026

4. Ventimiglia E, Westerberg M, Zaurito P, Tiago Bonde M, Robinson D, Gedeborg R, Stattin P, Garmo H. Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancer. Scand J Urol. 2026 Feb 4;61:16-22. Sammanfattning.

1. Da Silva M, Fritz J, Elhakeem A, Jochems SHJ, Sun M, Mboya IB, Häggström C, Wahlström J, Michaëlsson K, Magnusson PKE, Lagerros YT, Lönnberg L, Chabok A, Elmståhl S, Nwaru BI, Kankaanranta H, Hedman L, Backman H, Hägg S, Stattin P, Tilling K, Stocks T. Weight trajectories throughout adulthood and prostate cancer incidence, aggressiveness, and death in 258,494 men. J Natl Cancer Inst. 2026 Jan. Sammanfattning
2. Zaurito P, Garmo H, Gedeborg R, Alhberg M, Carlsson S, Thellenberg C, Robinson D, Stattin P, Westerberg M. Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study. BJU Int. 2026 Jan 15. Sammanfattning. Fulltext.
3. Wänman J, Farhang M, Nyström H, Styrke J, Häggström C, Stattin P, Crnalic S. Survival after spinal surgery for metastases in men with castration-sensitive vs castration-resistant prostate cancer: a nationwide register-based study. Sci Rep. 2026 Jan. Sammanfattning Fulltext